Sunshine Biopharma (SBFM) Return on Sales Growth (3y) (2018 - 2026)

Sunshine Biopharma (SBFM) Return on Sales Growth (3y) (2018 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS Growth (3y) (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 0.00
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 0.00
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 0.00
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 0.00
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 0.00
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 0.00
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -2.00
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 0.00
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 0.00
10 Sunshine Biopharma 10.94 Mn 4.03 Mn 2.18 Mn 0.00

Historic Data

Download Data
DateValue
Mar 31, 2026 0.00
Dec 31, 2025 6.00
Sep 30, 2025 11.00
Jun 30, 2025 3.00
Mar 31, 2025 10.00
Dec 31, 2024 -7.00
Sep 30, 2024 80.00
Jun 30, 2024 54.00
Mar 31, 2024 154.00
Jun 30, 2023 0.00
Mar 31, 2023 0.00
Dec 31, 2022 -6.00
Sep 30, 2022 -11.00
Jun 30, 2022 -3.00
Mar 31, 2022 0.00
Dec 31, 2021 10.00
Sep 30, 2021 -75.00
Jun 30, 2021 -48.00
Mar 31, 2021 -152.00
Mar 31, 2019 595.00